A study is presented for the synthesis of a series of 1‐tert‐butyl‐3(5)‐(trifluoromethyl)‐1H‐pyrazoles from the reaction of 4‐alkoxy‐1,1,1‐trifluoro‐3‐alken‐2‐ones [CF3C(O)CH=C(R1)(OR), where R = Et and R1 = H or R = Me and R1 = Me, Ph, 4‐Me‐C6H4, 4‐MeO‐C6H4, 4‐F‐C6H4, 4‐Cl‐C6H4, 4‐Br‐C6H4, 4‐I‐C6H4, fur‐2‐yl, thien‐2‐yl, or naphth‐2‐yl] with tert‐butylhydrazine hydrochloride. When [BMIM][BF4] (1‐butyl‐3‐methylimidazolium tetrafluoroborate) and pyridine were used as the reaction media, we obtained a mixture of 1‐tert‐butyl‐3(5)‐trifluoromethylpyrazoles. The formation of 5‐trifluoromethyl‐1‐tert‐butyl‐1H‐pyrazoles with high regioselectivity occurred when the reaction was carried out with NaOH in EtOH. The formation of 1‐tert‐butyl‐3‐trifluoromethyl‐1H‐pyrazoles occurred, after hydrolysis of the 4‐alkoxy‐1,1,1‐trifluoro‐3‐alken‐2‐ones in H2O and H2SO4, followed by cyclization in [BMIM][BF4] and pyridine.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2012) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: